Cristina-Loredana Pantea

Dr. Cristina-Loredana Pantea

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
Teofana-Otilia Bizerea-MogaTeofana-Otilia Bizerea-Moga
Teofana-Otilia Bizerea-Moga
LPLaura Pitulice
Laura Pitulice
Cristina-Loredana PanteaCristina-Loredana Pantea
Cristina-Loredana Pantea
OOOrsolya Olah
Orsolya Olah
OMOtilia Marginean
Otilia Marginean
Tudor Voicu MogaTudor Voicu Moga
Tudor Voicu Moga
Small and large birth weights (BWs) for gestational age (GA) represent extremes, but the correlation between extreme BW and metabolic syndrome (MetS) has not been fully elucidated. In this study, we examined this correlation in obese children based on changes in their metabolic profile from childhood to adolescence. A retrospective observational study was performed on 535 obese patients aged 0–18 years in the Clinical and Emergency Hospital for Children “Louis Turcanu” in Timisoara, Romania, based on clinical and biological data from January 2015 to December 2019. We emphasized the links between extreme BW and obesity, extreme BW and cardiometabolic risk, obesity and cardiometabolic risk, and extreme BW, obesity and MetS. Children born large for gestational age (LGA) predominated over those born small for gestational age (SGA). Our findings showed that BW has an independent effect on triglycerides and insulin resistance, whereas obesity had a direct influence on hypertension, impaired glucose metabolism and hypertriglyceridemia. The influences of BW and obesity on the development of MetS and its components are difficult to separate; therefore, large prospective studies in normal-weight patients are needed.

29 May 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Cristina-Loredana PanteaCristina-Loredana Pantea
Cristina-Loredana Pantea
MBMihaela Bataneant
Mihaela Bataneant
CZCristian G. Zimbru
Cristian G. Zimbru
BDBogdan Dragulescu
Bogdan Dragulescu
CMCatalin Vasile Munteanu
Catalin Vasile Munteanu
ACAdela Chirita-Emandi
Adela Chirita-Emandi
Inborn errors of immunity (IEI) are monogenic disorders with a wide spectrum of clinical phenotypes including immune dysregulation, autoimmunity, autoinflammation, and malignancy. IEI may have life-threatening consequences, thus precise and timely genetic diagnosis is crucial for improved access to treatment, genetic counselling and prevention. We aimed to investigate the genotypic findings in a cohort of children with IEI from Romania, in order to understand the diagnostic yield of genetic testing, genetic characterization of IEI and impact of genetic diagnosis. Clinical and genetic investigations were performed in 92 children (50% boys) with IEI phenotype, evaluated between 2018 and 2024, in a tertiary reference genetic center in Timisoara, Romania. Sanger sequencing, next generation sequencing panels with genes associated with IEI (1–474 genes), WES and WGS were used. Disease-causing variants for IEI (pathogenic/likely pathogenic) were identified in 37/92 (40.2%) participants, in 25 genes. 14/92 (15.2%) participants had relevant variants of uncertain significance. Median age at genetic testing was 4.38 (IQR 2–12.8) years. 15/37 (40.5%) of patients with Disease-causing variants had a family history of IEI. NGS gene panels were used in 43/92 (46.7%) patients, WES in 29 (31.5%), while WGS in 20 (21.7%). Twelve patients had more than one genetic test. Most frequent genes with Disease-causing variants identified were: JAGN1(5 patients) and AIRE(3). A great variety of genes were identified as causative for IEI. Considering the highly variable and unspecific phenotype, together with no family history in most cases, prioritizing genetic investigations offers the best option for timely diagnosis and treatment.

Verified
Journal Article
Open access
PDF file
Cristina-Loredana PanteaCristina-Loredana Pantea
Cristina-Loredana Pantea
MBMihaela Bataneant
Mihaela Bataneant
CJCiprian Jurcut
Ciprian Jurcut
ACAlexis-Virgil Cochino
Alexis-Virgil Cochino
AIAndreea Ioan
Andreea Ioan
ACAdela Chirita-Emandi
Adela Chirita-Emandi
Inborn errors of immunity (IEIs) encompass a heterogeneous group of more than 550 genetic conditions with variable ages of onset. A significant proportion of IEI arises from genetic variants that may not yet be fully elucidated or recorded in existing genomic databases. Molecular diagnoses are achieved in approximately 15–35% of IEI cases, yet in only 9–20% of individuals with predominant antibody deficiencies, particularly in adult cohorts. We aimed to evaluate whole genome sequencing (WGS) diagnostic yield in adults suspected to have IEI. Clinical assessments of the patients were carried out at tertiary medical institutions in Timisoara and Bucharest, Romania. The study cohort included a consecutive series of 21 adult patients (aged 19–60 years) with IEI phenotype, who underwent genetic analysis, using WGS as the first diagnostic approach. A definitive molecular diagnosis was confirmed in only 9.5% (2/21) of the participants, in LRBA and BTK genes. Variants of uncertain significance (VUS) were detected in three patients (13.6%) in TNFRSF13B, COPA, GATA2 genes. For about half of the cohort the onset of the disease was noted in childhood. WGS as a first-line diagnostic strategy in a cohort of adults with IEI yielded a low diagnostic rate. There were significant delays in genetic diagnosis, as half of the cohort experienced childhood-onset symptoms. Results suggest that adult IEI diagnosis remains challenging, necessitating functional studies and longitudinal re-evaluation of genomic data.

Verified
Journal Article
Open access
PDF file
Cristina-Loredana PanteaCristina-Loredana Pantea
Cristina-Loredana Pantea
MBMihaela Bataneant
Mihaela Bataneant
CZCristian ZIMBRU
Cristian ZIMBRU
MSMargit Serban
Margit Serban
MPMaria Puiu
Maria Puiu
ACAdela Chirita-Emandi
Adela Chirita-Emandi
More than 30 distinct genetic entities associated with severe congenital neutropenia (SCN) have been described. SCN has a risk of clonal expansion of mutated hematopoietic cells. Jagunal homolog 1 (JAGN1) deficiency has been described as a genetic cause of SCN and is now estimated to account for approximately 10% of all SCN cases. One prevalent variant in patients with JAGN1 deficiency is NM_032492.4:c.63G>T (p.Glu21Asp). The clinical description and disease evolution study of Romanian patients with JAGN1 deficiency caused by the JAGN1 c.63G>T variant were performed together with a literature review of similar cases. The clinical characterization of six Romanian patients and nine additional patients reported in the literature with JAGN1 deficiency caused by the c.63G>T variant (40% female) revealed a wide phenotypic spectrum, including: neutropenia (all), severe infections (80%), developmental delay (13%), dental problems such as stomatitis/periodontitis (66%), and short stature (7%). No patient developed malignancy/leukemia during the follow-up period (15 ± 8.1 years). Most patients (93%) had a homozygous variant and consanguineous background, while one had compound heterozygous JAGN1 variants. The five Romanian patients carrying this homozygous variant, possibly due to a founder effect, had a relatively favorable clinical outcome, with good overall prognosis.

25 May 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
Teofana-Otilia Bizerea-MogaTeofana-Otilia Bizerea-Moga
Teofana-Otilia Bizerea-Moga
Cristina-Loredana PanteaCristina-Loredana Pantea
Cristina-Loredana Pantea
GBGiorgiana-Flavia Brad
Giorgiana-Flavia Brad
OMOtilia Marginean
Otilia Marginean
Tudor Voicu MogaTudor Voicu Moga
Tudor Voicu Moga
Background and Clinical Significance: Pleural effusion results from an imbalance between fluid production and lymphatic drainage within the pleural space and may arise from a wide range of conditions. Chylothorax, characterized by the accumulation of chyle in the pleural cavity, is an uncommon cause of pleural effusion in the pediatric population. Although octreotide has been widely used in neonatal postoperative chylothorax, evidence supporting its role in acquired chylothorax beyond infancy remains limited, and dosing strategies are not standardized. This report describes the management of massive chylothorax in an adolescent patient. Case Presentation: A 13-year-old girl presented with fatigue, decreased exercise tolerance, vertigo, and diaphoresis and was diagnosed with massive right-sided chylothorax based on imaging and pleural fluid analysis. Treatment consisted of pleural drainage, dietary measures, and continuous intravenous octreotide administered within a multidisciplinary care framework. Chylous drainage declined progressively, with complete resolution of the effusion achieved without surgical intervention. Conclusions: Chylothorax in older children and adolescents may present with nonspecific symptoms and requires a high index of clinical suspicion. Early diagnosis, appropriate drainage, and individualized therapy are essential for favorable outcomes. Continuous octreotide infusion may represent an effective adjunctive treatment in selected pediatric cases, but further studies are needed to define optimal dosing and treatment duration.

1 January 2021 in Jurnalul Pediatrului
Verified
Journal Article
Open access
OOOrsolya Oláh
Orsolya Oláh
Cristina-Loredana PanteaCristina-Loredana Pantea
Cristina-Loredana Pantea
OTOtilia Teofana
Otilia Teofana
RTRaluca Tamasanu
Raluca Tamasanu
RARaluca Asproniu
Raluca Asproniu
OMOtilia Marginean
Otilia Marginean